Skip to main content

GT's Living Foods Recall: FDA Sampling found high levels of microcystins in Kombucha Multi Green.

United States

TerminatedClass II

Company
GT's Living Foods
Product
Synergy raw kombucha - Multi-Green; 16 fl. oz. (473 mL)…
Recall date
November 13, 2020
Terminated
January 27, 2021
Source
FDA

Reason for recall

FDA Sampling found high levels of microcystins in Kombucha Multi Green.

  1. - Recall initiated
  2. - Reported by source
  3. - Recall terminated
Recalled products
Product description UPC Quantity Lot / code information
Synergy raw kombucha - Multi-Green; 16 fl. oz. (473 mL) UPC 7 22430 14016 2 GT's Living Foods LLC Beverly Hills, CA Not published in this source record 1113 cases (12 x 16 oz. bottles per case) Lot 2028B2ES2 - Use By Date 12/18/2020; Lot 0628B1ET1- Use By Date 12/4/2020; Lot 1228B1ES2 - Use By Date 12/10/2020

Distribution

  • CT
  • MD
  • NH
  • NJ
  • PA

Official source record

Agency
FDA
Dataset
FDA Food Enforcement (Recalls)
Recall number
F-0137-2021
Event ID
86715
Status
Terminated
Classification
Class II
Company
GT's Living Foods
Product description
Synergy raw kombucha - Multi-Green; 16 fl. oz. (473 mL) UPC 7 22430 14016 2 GT's Living Foods LLC Beverly Hills, CA
Quantity
1113 cases (12 x 16 oz. bottles per case)
Reason
FDA Sampling found high levels of microcystins in Kombucha Multi Green.
Recall initiation date
November 13, 2020
Report date
December 2, 2020
Classification date
Not published in this source record
Termination date
January 27, 2021
Distribution pattern
CT, MD, NH, NJ, PA
UPC, lot, and code information
Lot 2028B2ES2 - Use By Date 12/18/2020; Lot 0628B1ET1- Use By Date 12/4/2020; Lot 1228B1ES2 - Use By Date 12/10/2020
Voluntary or mandated
Voluntary: Firm initiated
Initial notification method
Letter
Source last updated
Not tracked separately from the Public Health Trace retrieval date below
Public Health Trace retrieval date

Responsible company: GT's Living Foods

Distribution map

A map highlighting the states named in the source's distribution description.

Shading reflects state-level totals only, as published by the source. It does not imply county-level or point-level precision.

Distribution map
State Distributed
Connecticut 1
Maryland 1
New Hampshire 1
New Jersey 1
Pennsylvania 1

States shown are extracted from the source's free-text distribution description above; a narrative description (e.g. "distributed nationwide") may not list individual states to extract.

Where this information comes from

View FDA enforcement record -- the specific openFDA record this summary was built from.

No separate FDA public notice was found for this enforcement record. The information below comes from FDA's Recall Enterprise System through openFDA.

FDA Enforcement Reports -- FDA's general, official recall and enforcement information.

Technical source data

View raw source data -- the machine-readable record this page's information was built from.

Retrieved by Public Health Trace:

Frequently asked questions

What does a Class II mean?

A situation in which use of or exposure to a product may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.

Is this recall still active?

According to FDA, this recall's status is "Terminated." Always confirm the current status using the source links below, since status can change after Public Health Trace last retrieved this record.

What should I do if I have this product?

Follow the instructions published by the responsible agency (see the source links below) -- recall guidance (e.g. dispose of the product, return it for a refund, or check for a specific lot number) varies by recall and is set by that agency, not by Public Health Trace.

Where can I find more official information?

The source links below, published by FDA, are the authoritative record for this recall, including any updates issued after this summary was retrieved.

This summary is based on the official source record referenced above. Public Health Trace does not state that any company or product is unsafe beyond what the official source has published. Read the full medical disclaimer.